$VXRT Cummings has clinical trial experience, expertise in vaccine development, robust industry network which will help Vaxy achieve it’s strategic objectives. Cummings said: “Bringing Vaxart's potentially game-changing tablet vaccine to market will make it easier to vaccinate global population as we continue our fight against COVID-19 & other potentially deadly diseases including norovirus & flu. I am grateful for the chance to be a part of this dynamic team & join their mission to improve human health through preventative medicines." It’s only 3-4 months since he joined. Give him time. This is akin to rocket science, not making caesar salad. His glittering career: 1. Director of Department of Defense's Global Emerging Infectious Surveillance & Response System (GEIS). 2. Director of Translational Medicine & Regulated Activities for the Walter Reed Army Institute of Research (WRAIR), Consultant to Surgeon General for all medical research & development. 3. President at Icon GPHS.